The conundrum of clinical trials in adult germ-cell tumours

被引:2
|
作者
Powles, Thomas [1 ]
Kollmannsberger, Christian [2 ]
Feldman, Darren R. [3 ]
机构
[1] Queen Mary Univ London, Barts Canc Inst, St Bartholomews Hosp, London EC1A 7BE, England
[2] British Columbia Canc Agcy, Christian Kurt Div Med Oncol, Vancouver, BC V5Z 4E6, Canada
[3] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
来源
LANCET ONCOLOGY | 2013年 / 14卷 / 01期
关键词
MEDICAL-RESEARCH-COUNCIL; RANDOMIZED PHASE-III; EUROPEAN ORGANIZATION; CISPLATIN; ETOPOSIDE; CANCER; BLEOMYCIN; CHEMOTHERAPY; IFOSFAMIDE; INTERGROUP;
D O I
10.1016/S1470-2045(12)70561-2
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:14 / 15
页数:3
相关论文
共 50 条
  • [1] Management of good risk germ-cell tumours
    Troost, Monique M.
    Sternberg, Cora N.
    de Wit, Ronald
    BJU INTERNATIONAL, 2009, 104 (9B) : 1387 - 1391
  • [2] Paediatric extracranial germ-cell tumours
    Shaikh, Furqan
    Murray, Matthew J.
    Amatruda, James F.
    Coleman, Nicholas
    Nicholson, James C.
    Hale, Juliet P.
    Pashankar, Farzana
    Stoneham, Sara J.
    Poynter, Jenny N.
    Olson, Thomas A.
    Billmire, Deborah F.
    Stark, Daniel
    Rodriguez-Galindo, Carlos
    Frazier, A. Lindsay
    LANCET ONCOLOGY, 2016, 17 (04): : E149 - E162
  • [3] Delivered relative dose intensity in adolescent and young adult germ cell tumours in England: Assessment of data quality and consistency from clinical trials compared to national cancer registration data
    Hughes, Nicola F.
    Cromie, Kirsten J.
    Feltbower, Richard G.
    Mccabe, Martin G.
    Stark, Dan
    INTERNATIONAL JOURNAL OF CANCER, 2024, 154 (05) : 816 - 829
  • [4] Germ-cell tumours containing non germ-cell neoplasms: teratoma with malignant transformation
    Rebischung, C
    Cottu, PH
    Daban, A
    Terrier-Lacombe, MJ
    Theodore, C
    Bonvalot, S
    Vallancien, G
    Culine, S
    Fizazi, K
    UROLOGIC ONCOLOGY, 2001, 6 (06): : 239 - 242
  • [5] Germ cell tumor clinical trials in North America
    Bosl, GJ
    SEMINARS IN SURGICAL ONCOLOGY, 1999, 17 (04): : 257 - 262
  • [6] Genomic evolution and chemoresistance in germ-cell tumours
    Taylor-Weiner, Amaro
    Zack, Travis
    O'Donnell, Elizabeth
    Guerriero, Jennifer L.
    Bernard, Brandon
    Reddy, Anita
    Han, G. Celine
    AlDubayan, Saud
    Amin-Mansour, Ali
    Schumacher, Steven E.
    Litchfield, Kevin
    Turnbull, Clare
    Gabriel, Stacey
    Beroukhim, Rameen
    Getz, Gad
    Carter, Scott L.
    Hirsch, Michelle S.
    Letai, Anthony
    Sweeney, Christopher
    Van Allen, Eliezer M. .
    NATURE, 2016, 540 (7631) : 114 - +
  • [7] Consensus on the management of intracranial germ-cell tumours
    Murray, Matthew J.
    Bartels, Ute
    Nishikawa, Ryo
    Fangusaro, Jason
    Matsutani, Masao
    Nicholson, James C.
    LANCET ONCOLOGY, 2015, 16 (09): : E470 - E477
  • [8] The clinical features and management of testicular germ cell tumours in patients aged 60 years and older
    Wheater, Matthew J.
    Manners, James
    Nolan, Luke
    Simmonds, Peter D.
    Hayes, Matthew C.
    Mead, Graham M.
    BJU INTERNATIONAL, 2011, 108 (11) : 1794 - 1799
  • [9] Surveillance or adjuvant treatments in stage 1 testis germ-cell tumours
    Cullen, M.
    ANNALS OF ONCOLOGY, 2012, 23 : 342 - 348
  • [10] Compliance with guidelines and correlation with outcome in patients with advanced germ-cell tumours
    Thibault, Constance
    Fizazi, Karim
    Barrios, Daniel
    Massard, Christophe
    Albiges, Laurence
    Baumert, Herve
    Patard, Jean-Jacques
    Escudier, Bernard
    Loriot, Yohann
    EUROPEAN JOURNAL OF CANCER, 2014, 50 (07) : 1284 - 1290